ReviewEndocrine2016
Omarigliptin for the treatment of type 2 diabetes.
Xueying TanPubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewEndocrine2016
Xueying TanPubMed ↗Publisher ↗
No numbers read from the abstract.